EUDA HEALTH HOLDINGS LTD
EUDANASDAQTrading Snapshot
- Day Range
- $14.70 – $15.02
- 52-Week Range
- $5.26 – $86.00
- Volume
- $2.93B
- Avg Volume
- $2.43B
- Shares Outstanding
- 1.9M
- Next Earnings
- Oct 9, 2026
Fundamentals Snapshot
- Annual Revenue
- $7M
- Last Q Revenue
- $7M
- P/E Ratio
- -13.9
- P/S Ratio
- 2.4x
- EPS (TTM)
- $-2.55
- Dividend Yield
- 0.00%
Why Investors Own EUDA
- ✓High-growth profile — revenue up +54.9% YoY with expanding US Equity exposure.
- ✓Healthy economics — 33% gross margin and 22% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About EUDA HEALTH HOLDINGS LTD
EUDA Health Limited, established in 2019, is a Singapore-based enterprise dedicated to advancing digital healthcare. It provides an innovative platform facilitating online medical consultations for routine, non-urgent health concerns. This entity functions as a subsidiary of Watermark Developments Limited.
Otter Score Breakdown
ⓘAnalyst Ratings
ⓘLatest News & Updates
EUDA Health Collaborates With GO POSB Organoids And Shenzhen Innovation To Develop Next‑Gen Off‑the‑Shelf iPSC‑Based NK Cell Therapies For Wellness And Oncology Across Asia
EUDA Health Holdings Limited (NASDAQ:EUDA) a Singapore-based distributor of third-party provided wellness and non-invasive healthcare products and services in Asia, with a focus on Singapore, Malaysia and China, today
EUDA Health Signs MoU With GO POSB Organoids And Shenzhen Innovation Immunotechnology To Collaborate On Therapies Derived From Induced Pluripotent Stem Cells
The MOU details the parties intentions to collaborate on the development, manufacturing and commercialization of a first of its kind next generation of off-the-shelf oncology cell therapies for cancer treatment
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Entera Bio (NASDAQ:ENTX) stock moved upwards by 86.6% to $3.83 during Monday's regular session. The company's market cap stands at $100.9 million. Gossamer Bio (NASDAQ:GOSS) shares moved upwards by
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Jasper Therapeutics (NASDAQ:JSPR) stock moved upwards by 19.2% to $0.92 during Friday's regular session. The company's market cap stands at $21.6 million. Kalaris Therapeutics (NASDAQ:KLRS) shares